Archives
-
Sulfo-NHS-LC-Biotin Protocol and QC Guide
2026-08-13
Sulfo-NHS-LC-Biotin provides aqueous, irreversible biotin labeling of primary amines on proteins, peptides, and accessible cell-surface proteins. It is appropriate for stable detection, capture, and purification workflows, but not for intracellular labeling or applications requiring reversible biotin attachment.
-
EdU Imaging Kits: From S-Phase Signal to HCC Insight
2026-08-12
EdU Imaging Kits (HF488) connect direct 5-ethynyl-2'-deoxyuridine DNA synthesis measurement with modern hepatocellular carcinoma research. This guide explains how to translate an EdU cell proliferation assay into interpretable phenotypic evidence alongside AI-derived risk stratification.
-
ML133 HCl: Reading Kir2.1 Assays
2026-08-12
ML133 HCl is a selective potassium channel inhibitor for dissecting Kir2.1-dependent potassium ion transport and vascular remodeling. This article presents a pH-aware, evidence-based framework for connecting channel engagement with pulmonary artery smooth muscle cell phenotypes.
-
V5 Epitope Tag Peptide in Viability Assays
2026-08-11
Learn how V5 Epitope Tag Peptide SKU A6005 can strengthen interpretation of cell viability, proliferation, and cytotoxicity experiments by separating protein-expression measurements from functional assay endpoints. This scenario-based guide covers construct design, peptide handling, antibody kinetics, data interpretation, and practical product selection.
-
Perifosine (KRX-0401) Assay Workflows
2026-08-11
Build reproducible Perifosine workflows for Akt-driven apoptosis, pathway profiling, and radiation sensitization in cancer models. The article also translates a stroke-focused PI3K/Akt/mTOR study into practical assay design without overstating neuroprotective conclusions.
-
Anlotinib Hydrochloride for Angiogenesis Assays
2026-08-10
Anlotinib hydrochloride combines potent VEGFR2 activity with PDGFRβ and FGFR1 coverage, making it useful for dissecting endothelial migration, tube formation, and ERK-dependent angiogenesis. This workflow-focused guide shows how to select concentrations, connect functional readouts with receptor signaling, and troubleshoot variability in cancer research assays.
-
Vacuolin-1 and the Next Precision of Lysosomal Biology
2026-08-09
A mechanistic and translational guide to using Vacuolin-1 to dissect lysosomal exocytosis, membrane repair, calcium-dependent trafficking, and disease-linked growth factor disruption.
-
Concanavalin A Targets Conserved Coronavirus N-Glycans
2026-08-08
A 2026 Journal of Virology study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad-spectrum antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and mouse infection models, the authors show that concanavalin A blocks spike activation and viral entry rather than targeting rapidly changing antibody epitopes.
-
CUDC-907 Protocol for PI3K/HDAC Studies
2026-08-07
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone deacetylase activity, cell-cycle progression, and apoptosis. This article provides dossier-based setup and QC guidance; the compound is for scientific research only and should not be used for diagnostic, therapeutic, or clinical applications.
-
AP20187: Transforming Conditional Gene Therapy with Precisio
2026-08-07
Explore how AP20187 as a chemical inducer of dimerization bridges mechanistic rigor with translational promise, empowering researchers to control gene expression and cellular behavior for next-generation therapies. This article integrates foundational science, competitive analysis, and strategy for deploying APExBIO’s AP20187 in regulated cell therapy and disease modeling, with direct evidence from recent tumor microenvironment research.
-
Bovine Insulin (A5981): Precision Growth Factor for Cell Cul
2026-08-06
Bovine insulin is a double-chain peptide hormone from the bovine pancreas that enhances glucose metabolism and cell proliferation in vitro. Supplied by APExBIO at ≥98% purity, this reagent is a high-confidence growth factor supplement for cultured cells. Solubility and workflow parameters make it ideal for reproducible metabolic and signaling studies.
-
PYR-41: Selective Inhibitor of Ubiquitin-Activating Enzyme E
2026-08-06
PYR-41 is a small molecule inhibitor of Ubiquitin-Activating Enzyme E1, effectively blocking ubiquitin-proteasome system function in vitro and in vivo. It provides a robust tool for dissecting protein degradation and NF-κB signaling, with clear benchmarks in inflammation and sepsis models. This dossier details its mechanisms, use parameters, and boundaries for research applications.
-
Acifran and the Structural Revolution in Lipid Metabolism Re
2026-08-05
This thought-leadership article explores how Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) is reshaping lipid metabolism research. Anchored in recent cryo-EM breakthroughs, it offers mechanistic clarity and strategic insight for translational scientists tackling metabolic disorders. The article integrates evidence from landmark studies and contextualizes Acifran’s unique advantages over conventional agents, providing actionable guidance for experimental design and translational impact.
-
Ceapin-A7 as a Selective ER Stress Blocker: Workflow and Ins
2026-08-05
Ceapin-A7 stands out as a highly selective ER stress blocker, enabling precise modulation of the ATF6α pathway for advanced cell biology research. This guide demystifies its application, from protocol refinement to troubleshooting, leveraging new mechanistic insights into ER stress signaling and pyroptosis.
-
Concanavalin A Targets Conserved N-Glycans for Pan-Coronavir
2026-08-04
Guo et al. demonstrate that concanavalin A (ConA) binds to phylogenetically conserved N-linked glycans on coronavirus spike proteins, broadly inhibiting viral entry by blocking membrane fusion. This approach identifies stable glycan targets for pan-coronavirus therapeutics and informs strategies for antiviral development.